Chinese PLA General Hospital
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
Papers in
- Hepatology 868
- Hepatocellular Carcinoma Treatment and Prognosis 528
- Cancer Research 1.5k
- Cancer-related molecular mechanisms research 530
- MicroRNA in disease regulation 494
- Top scholars
- Xiaobing FuWeidong HanXiangmei ChenHao ZhouPing LiangGuozhen ShenYong-ming YaoKai Jiang
- Journals
- Scientific Reports (315 papers)PLoS ONE (268 papers)Medicine (196 papers)Frontiers in Oncology (184 papers)Frontiers in Immunology (178 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Chinese PLA General Hospital
20.2k papers receiving 370.1k citations
Peers
Comparison fields: 5 of 243
- Cancer Research 38.3k
- Oncology 40.9k
- Molecular Biology 110.6k
- Hepatology 11.1k
- Rehabilitation 9.3k
Countries citing scholars working at Chinese PLA General Hospital
This map shows the geographic impact of research produced by authors working at Chinese PLA General Hospital. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Chinese PLA General Hospital with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chinese PLA General Hospital more than expected).
Fields of papers published by authors at Chinese PLA General Hospital
This network shows the impact of papers affiliated with Chinese PLA General Hospital at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Chinese PLA General Hospital at the time of their publication.
About Chinese PLA General Hospital
In recent decades, authors affiliated with Chinese PLA General Hospital have published 27.1k papers, which have received a total of 450.1k indexed citations . Scholars at this organization have produced 868 papers in Hepatology, 1.5k papers in Cancer Research, 2.6k papers in Pulmonary and Respiratory Medicine, 2.2k papers in Oncology and 412 papers in Sensory Systems on the topics of Cancer-related molecular mechanisms research (530 papers), Hepatocellular Carcinoma Treatment and Prognosis (528 papers), MicroRNA in disease regulation (494 papers), RNA modifications and cancer (425 papers), Mesenchymal stem cell research (423 papers), Hearing, Cochlea, Tinnitus, Genetics (376 papers), Liver Disease Diagnosis and Treatment (357 papers) and Cancer Immunotherapy and Biomarkers (355 papers). Their work is cited by papers focused on Cancer Research (38.3k citations), Oncology (40.9k citations), Molecular Biology (110.6k citations), Hepatology (11.1k citations) and Rehabilitation (9.3k citations). Authors at Chinese PLA General Hospital collaborate with scholars in China, United States and Philippines and have published in prestigious journals including Scientific Reports, PLoS ONE, Medicine, Frontiers in Oncology and Frontiers in Immunology. Some of Chinese PLA General Hospital's most productive authors include Xiaobing Fu, Weidong Han, Xiangmei Chen, Hao Zhou, Ping Liang, Guozhen Shen, Yong-ming Yao, Kai Jiang, Peifu Tang and Yundai Chen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.